Compare ADMA Biologics Inc (ADMA) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Keysight Technologies Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Keysight Technologies Inc trades at $346.15 (market cap $58.74B). The key difference: Keysight Technologies Inc is far larger — about 26.5× ADMA Biologics Inc's market cap, and Keysight Technologies Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | KEYS | |
|---|---|---|
Market Cap | $2.22B | $58.74B |
Sector | Health | Technology |
52-Week High | $20.38 | $373.34 |
52-Week Low | $7.60 | $158.51 |
Enterprise Value | $2.29B | $59.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
